Bleeding risk evaluation in cerebral cavernous malformation, the role of medications, and hemorrhagic factors: a case-control study

CONCLUSIONS: This study supports previous findings that the CCM volume is the only factor influencing the bleeding risk. Antithrombotic agents and propranolol seem to have a protective role against the bleeding events. A high HAS-BLED score was not associated with an increased bleeding risk. Further studies are needed to confirm these results.PMID:37778034 | DOI:10.3171/2023.7.FOCUS23355

Source: Neurosurgical Focus - October 1, 2023 Category: Neurosurgery Authors: Alba Scerrati Giorgio Mantovani Francesco Travaglini Leonardo Bradaschia Pasquale De Bonis Marco Farneti Michele Alessandro Cavallo Flavia Dones Maria Elena Flacco Anna Maria Auricchio Alberto Benato Alessio Albanese Carmelo Lucio Sturiale Source Type: research